Jorun Holm - Publications

Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET/ceCT Versus Na[18F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial.

Journal: European urology open science

Published: May 10, 2026

Prognostic value of the SENTIREC-endo algorithm integrating sentinel lymph node and FDG-PET/CT in staging high-risk endometrial cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 09, 2026

Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [18F]PSMA-1007 PET/CT and [18F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 02, 2025

Diagnostic Accuracy and Interrater Agreement of FDG-PET/CT Lymph Node Staging in High-Risk Endometrial Cancer: The SENTIREC-Endo Study.

Journal: Cancers

Published: June 10, 2025

Title Not Found

Journal: Ugeskrift for laeger

Published: September 02, 2024

A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.

Journal: BJUI compass

Published: February 24, 2023

Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 14, 2022

Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.

Journal: Gynecologic oncology

Published: July 06, 2022

From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?

Journal: Gynecologic oncology

Published: July 28, 2021

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: November 05, 2020

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: October 07, 2020

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.

Journal: Cancers

Published: July 20, 2019